Neurocrine Bio. (NBIX) PT Raised to $131 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $152.72 --0%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 19
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 19
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $131.00 (from $125.00) while maintaining a Buy rating.
You May Also Be Interested In
- Deutsche Bank Downgrades Workday (WDAY) to Hold
- Harley-Davidson (HOG) PT Raised to $33 at DA Davidson
- Nyxoah SA (NYXH) PT Lowered to $6 at Cantor Fitzgerald to Reflect Current Trading Levels
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
